HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

pinacolyl methylphosphonic acid

soman metabolite; structure given in first source
Also Known As:
PMPA
Networked: 67 relevant articles (14 outcomes, 14 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bischofberger, N: 4 articles (08/2001 - 02/2000)
2. Babich, John W: 3 articles (02/2015 - 09/2009)
3. Holý, Antonín: 3 articles (06/2009 - 08/2003)
4. Vanham, Guido: 3 articles (07/2008 - 01/2005)
5. Marquis, John C: 2 articles (08/2013 - 09/2009)
6. Eckelman, William C: 2 articles (08/2013 - 09/2009)
7. Zimmerman, Craig N: 2 articles (08/2013 - 09/2009)
8. Hillier, Shawn M: 2 articles (08/2013 - 09/2009)
9. Joyal, John L: 2 articles (08/2013 - 09/2009)
10. Maresca, Kevin P: 2 articles (08/2013 - 09/2009)

Related Diseases

1. Infection
2. Viremia
3. Retroviridae Infections (Infection, Retrovirus)
10/01/2003 - "The acyclic nucleoside phosphonates HPMPC (cidofovir), PMEA (adefovir), and PMPA (tenofovir) have proved to be effective in vitro (cell culture systems) and in vivo (animal models and clinical studies) against a wide variety of DNA virus and retrovirus infections: cidofovir against herpesvirus (herpes simplex virus types 1 and 2 varicella-zoster virus, cytomegalovirus [CMV], Epstein-Barr virus, and human herpesviruses 6, 7, and 8), polyomavirus, papillomavirus, adenovirus, and poxvirus (variola virus, cowpox virus, vaccinia virus, molluscum contagiosum virus, and orf virus) infections; adefovir against herpesvirus, hepadnavirus (human hepatitis B virus), and retrovirus (human immunodeficiency virus types 1 [HIV-1] and 2 [HIV-2], simian immunodeficiency virus, and feline immunodeficiency virus) infections; and tenofovir against both hepadnavirus and retrovirus infections. "
06/01/2003 - "The acyclic nucleoside phosphonates [HPMPC: cidofovir, Vistide; PMEA: adefovir dipivoxil, Hepsera; and PMPA: tenofovir, Viread] have proven to be effective in vitro (cell culture systems) and in vivo (animal models and clinical studies) against a wide variety of DNA virus and retrovirus infections, for example, cidofovir against herpesvirus [herpes simplex virus type 1 and 2, varicella-zoster virus, cytomegalovirus, Epstein-Barr virus, human herpesvirus type 6, 7 and 8), polyoma-, papilloma-, adeno- and poxvirus (variola virus, cowpox virus, vaccinia virus, molluscum contagiosum virus and orf) infections; adefovir against herpesvirus, hepadnavirus [human hepatitis B virus] and retrovirus [HIV type-1 and 2, simian immunodeficiency virus and feline immunodeficiency virus] infections; and tenofovir against both hepadna- and retrovirus infections. "
4. Acquired Immunodeficiency Syndrome (AIDS)
5. Papilloma (Papillomatosis)

Related Drugs and Biologics

1. tenofovir
2. Adenine
3. Phosphonic Acids (Phosphonates)
4. cidofovir (Vistide)
5. adefovir
6. RNA-Directed DNA Polymerase (Reverse Transcriptase)
7. tenofovir disoproxil (Viread)
8. adefovir dipivoxil (Hepsera)
9. Reverse Transcriptase Inhibitors
10. Phosphorus

Related Therapies and Procedures

1. Immunomodulation
2. Highly Active Antiretroviral Therapy (HAART)
3. Heterologous Transplantation (Xenotransplantation)
4. Drug Therapy (Chemotherapy)